Biologics

Promote Corneal Healing with Opticyte Amniotic Ocular Matrix

Merakris Therapeutics is a leader in researching, developing, and marketing regenerative healthcare products. They are pioneering commercially scalable biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. The Merakris vision is to improve global patient care and outcomes through the pioneering and innovation of cellular regenerative biotechnologies.

Merakris Therapeutics ocular tissue technology is based on a sophisticated and delicate manufacturing process intended to retain extracellular matrix properties and structures. This makes it ideal for ocular applications.

• Processed without harsh chemical reagents that may cause irritation when placed in the corneal bed.
• Opticyte Matrix provides an ophthalmic barrier to the corneal surface and supports cell attachment and ingrowth.
• Minimal scarring is observed in Opticyte Matrix-protected corneas during healing and re-epithelialization

And the Merakris difference means the highest quality products, fast shipments, technical support and reimbursement guidance.